Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 46-52, 2006. First published October 27, 2005; 10.1373/clinchem.2005.056192
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2005.056192v1
52/1/46    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia-Barceló, M.
Right arrow Articles by Tam, P. K.-h.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia-Barceló, M.
Right arrow Articles by Tam, P. K.-h.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2006;52:46-52.)
© 2006 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Population Differences in the Polyalanine Domain and 6 New Mutations in HLXB9 in Patients with Currarino Syndrome

Mercè Garcia-Barceló1,2, Man-ting So1,2, Danny Ko-chun Lau1, Thomas Yuk-yu Leon1, Zheng-wei Yuan1,3, Wei-song Cai1,3, Vincent Chi-hang Lui1, Ming Fu1,4, Jo-Anne Herbrick5, Emily Gutter6, Virginia Proud6, Long Li4, Jacqueline Pierre-Louis7, Kirk Aleck8, Ernest van Heurn9, Elena Belloni10, Stephen W. Scherer5 and Paul Kwong-hang Tam1,2,a

1 Department of Surgery, 2 Genome Research Center, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
3 Department of Pediatric Surgery, China Medical University, Shenyang, China.
4 Department of Surgery, Beijing Children’s Hospital, Beijing, China.
5 Program in Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Canada.
6 Department of Pediatrics, Children’s Hospital of the King’s Daughters, Norfolk, VA.
7 Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
8 St. Joseph’s Hospital, CHC Phoenix Genetics Program, Phoenix, AZ.
9 Surgical Unit, University Hospital, Maastricht, The Netherlands.
10 IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, and IEO, Istituto Europero di Oncologia, Milan, Italy.

aAddress correspondence to this author at: Division of Paediatric Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong SAR, China. Fax 852-2817-3155; e-mail paultam{at}hkucc.hku.hk.

Background: The combination of partial absence of the sacrum, anorectal anomalies, and presacral mass constitutes Currarino syndrome (CS), which is associated with mutations in HLXB9.

Methods: We analyzed 5 CS families and 6 sporadic cases for HLXB9 mutations by direct sequencing. Potentially pathologic expansions of HLXB9 GCC repeats were analyzed in patients, 4 general populations [Chinese, Japanese, Yoruba, and Centre du Etude Polymorphisme Human (CEPH)] from the HapMap project, and 145 healthy Chinese.

Results: We identified 6 novel mutations affecting highly conserved residues (Ser185X, Trp215X, Ala26fs, Ala75fs, Met1Ile, and Arg273Cys). GCC allele and genotype distributions showed marked statistically significant differences. (GCC)11 was the most common allele overall; its frequency ranged from 90% in CEPH to 68% in Yoruba and 50% in Chinese and Japanese populations. (GCC)9 was almost as common as (GCC)11 in Chinese and Japanese populations, whereas its frequency was <10% in Yoruba and CEPH populations. The Yoruba population had the highest frequency of the largest alleles [(GCC)12 and (GCC)13], which were almost absent in the other groups.

Conclusions: Lack of HLXB9 mutations in some patients and the presence of variable phenotypes suggest DNA alterations in HLXB9 noncoding regions and/or in other genes encoding HLXB9 regulatory molecules or protein partners. If HLXB9, like other homeobox genes, has a threshold beyond which triplet expansions are pathologic, those populations enriched with larger alleles would be at a higher risk. The data illustrate the importance of ethnicity adjustment if these polymorphic markers are to be used in association studies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.